|
100
|
249
|
3aunA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with yr335 and a synthetic peptide containing the nr2 box of drip 205 |
|
104
|
274
|
3an3A |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mo3s |
|
92
|
274
|
3aduA |
Human ppargamma ligand-binding domain in complex with 5-methoxy-indole acetate |
|
101
|
274
|
3adxA |
Human ppargamma ligand-binding domain in complex with indomethacin and nitro-233 |
|
103
|
274
|
3adsA |
Human ppargamma ligand-binding domain in complex with indomethacin |
|
98
|
274
|
3adtA |
Human ppargamma ligand-binding domain in complex with 5-hydroxy-indole acetate |
|
104
|
272
|
3an4A |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mo4r |
|
100
|
274
|
3advA |
Human ppargamma ligand-binding domain in complex with serotonin |
|
91
|
239
|
3a9eB |
Crystal structure of a mixed agonist-bound rar-alpha and antagonist-bound rxr-alpha heterodimer ligand binding domains |
|
100
|
251
|
3afrA |
Crystal structure of vdr-lbd/22s-butyl-1a,24r-dihydroxyvitamin d3 complex |
|
100
|
274
|
3adwA |
Human ppargamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid |
|
78
|
232
|
3a9eA |
Crystal structure of a mixed agonist-bound rar-alpha and antagonist-bound rxr-alpha heterodimer ligand binding domains |
|
79
|
230
|
2zxzA |
Crystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide |
|
100
|
255
|
3a2iA |
Crystal structure of the human vitamin d receptor (h305f) ligand binding domain complexed with tei-9647 |
|
95
|
252
|
3a2hA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with tei-9647 and a synthetic peptide containing the nr2 box of drip 205 |
|
92
|
251
|
2zxmA |
A new class of vitamin d receptor ligands that induce structural rearrangement of the ligand-binding pocket |
|
101
|
255
|
3a3zX |
Crystal structure of the human vdr ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-amcr277a(c23s) |
|
99
|
255
|
3a2jA |
Crystal structure of the human vitamin d receptor (h305f/h397f) ligand binding domain complexed with tei-9647 |
|
103
|
255
|
3a40X |
Crystal structure of the human vdr ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-amcr277b(c23r) |
|
99
|
251
|
2zxnA |
A new class of vitamin d receptor ligands that induce structural rearrangement of the ligand-binding pocket |
|
102
|
255
|
3a78A |
Crystal structure of the human vdr ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin d3 |
|
100
|
274
|
2zvtA |
Cys285ser mutant ppargamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin j2 |
|
78
|
232
|
2zy0A |
Crystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide |
|
100
|
268
|
2znqA |
Human ppar delta ligand binding domain in complex with a synthetic agonist tipp401 |
|
100
|
251
|
2zlaA |
2-substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin d3 analogs: synthesis, biological evaluation and crystal structure |
|
99
|
252
|
2zfxA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with yr301 and a synthetic peptide containing the nr2 box of drip 205 |
|
101
|
274
|
2zk2A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin j2 |
|
79
|
238
|
2z4bA |
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand |
|
101
|
253
|
2zmiA |
Crystal structure of rat vitamin d receptor bound to adamantyl vitamin d analogs: structural basis for vitamin d receptor antagonism and/or partial agonism |
|
96
|
250
|
2zl9A |
2-substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin d3 analogs: synthesis, biological evaluation and crystal structure |
|
94
|
274
|
2znoA |
Human ppar gamma ligand binding domain in complex with a synthetic agonist tipp703 |
|
89
|
226
|
2zkcA |
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol z |
|
91
|
266
|
2znpA |
Human ppar delta ligand binding domain in complex with a synthetic agonist tipp204 |
|
97
|
251
|
2zmjA |
Crystal structure of rat vitamin d receptor bound to adamantyl vitamin d analogs: structural basis for vitamin d receptor antagonism and/or partial agonism |
|
94
|
274
|
2zk1A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin j2 |
|
94
|
248
|
2z4jA |
Crystal structure of ar lbd with shp peptide nr box 2 |
|
98
|
274
|
2zk5A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233 |
|
96
|
251
|
2zlcA |
2-substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin d3 analogs: synthesis, biological evaluation and crystal structure |
|
95
|
274
|
2zk4A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid |
|
88
|
227
|
2zbsA |
Crystal structure of human estrogen-related receptor gamma ligand binding domain apo form |
|
103
|
267
|
2znnA |
Human ppar alpha ligand binding domain in complex with a synthetic agonist tipp703 |
|
98
|
251
|
2zmhA |
Crystal structure of rat vitamin d receptor bound to adamantyl vitamin d analogs: structural basis for vitamin d receptor antagonism and/or partial agonism |
|
95
|
274
|
2zk6A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with c8-bodipy |
|
88
|
270
|
2zk0A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain |
|
97
|
274
|
2zk3A |
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid |
|
88
|
227
|
2zasA |
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alpha-cumylphenol, a bisphenol a derivative |
|
95
|
249
|
2ylqA |
Targeting the binding function 3 site of the androgen receptor through in silico molecular modeling |
|
101
|
275
|
2yfeA |
Ligand binding domain of human ppar gamma in complex with amorfrutin 1 |
|
100
|
250
|
2yloA |
Targeting the binding function 3 site of the androgen receptor through in silico molecular modeling |
|
97
|
245
|
2yjaB |
Stapled peptides binding to estrogen receptor alpha. |
